Who Exports Clopidogrel from India — 416 Suppliers Behind a $251.3M Market
India's clopidogrel export market is supplied by 416 active exporters who collectively shipped $251.3M across 6,037 shipments. AUROBINDO PHARMA LTD leads with a 17.2% market share, followed by MACLEODS PHARMACEUTICALS LTD and ZENTIVA PRIVATE LIMITED. The top 5 suppliers together control 50.2% of total export value, reflecting a moderately competitive market structure.
Top Clopidogrel Exporters from India — Ranked by Export Value
AUROBINDO PHARMA LTD is the leading clopidogrel exporter from India, holding a 17.2% share of the $251.3M market across 6,037 shipments from 416 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, MACLEODS PHARMACEUTICALS LTD, ZENTIVA PRIVATE LIMITED, DR.REDDY'S LABORATORIES LTD, AUROBINDO PHARMA LIMITED — collectively control 50.2% of total export value, indicating a moderately concentrated market. Individual shares are: AUROBINDO PHARMA LTD (17.2%), MACLEODS PHARMACEUTICALS LTD (13.4%), ZENTIVA PRIVATE LIMITED (7.6%), DR.REDDY'S LABORATORIES LTD (7.1%), AUROBINDO PHARMA LIMITED (4.9%).
Top Clopidogrel Exporters from India
Ranked by export value · 416 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AUCLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLA | $43.2M | 11 | 17.2% |
| 2 | MACLEODS PHARMACEUTICALS LTD CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'S | $33.7M | 16 | 13.4% |
| 3 | ZENTIVA PRIVATE LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AR | $19.1M | 7 | 7.6% |
| 4 | DR.REDDY'S LABORATORIES LTD CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'S | $17.8M | 15 | 7.1% |
| 5 | AUROBINDO PHARMA LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AUCLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLA | $12.4M | 6 | 4.9% |
| 6 | FREDUN PHARMACEUTICALS LTD CLODOR CLOPIDOGREL BESYLATE 75 MGOTHER - DEPLATT 75 TABLET (CLOPIDOGREL B | $12.1M | 3 | 4.8% |
| 7 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 2X14'SPHARMACEUTICAL PRODUCTS - CLOPIDOGREL ZE | $8.7M | 2 | 3.5% |
| 8 | AJANTA PHARMA LIMITED CLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL ARHARMLESS MEDICINES, CLOPIDOGREL/ACIDE AC | $8.5M | 18 | 3.4% |
| 9 | SANDOZ PRIVATE LIMITED CLOPIDOGREL 75MG TABLETSCLOPIDOGREL 75MG TABLETS (EACH TAB CONT.CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 M | $8.3M | 7 | 3.3% |
| 10 | MYLAN LABORATORIES LIMITED CLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL ARHARMLESS MEDICINES, CLOPIDOGREL/ACIDE AC | $8.0M | 3 | 3.2% |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED CLOPIDOGREL BISULPHATE TAB 75MG PACK:4X7CLOPIDOGREL BISULPHATE TAB 75MG PACK:BOXCLOPIDOGREL TABLETS 75MG(BISSULFATO DE C | $7.9M | 13 | 3.1% |
| 12 | UNICHEM LABORATORIES LIMITED CLOPIDOGREL 75MG TABLETSCLOPIDOGREL 75MG TABLETS (EACH TAB CONT.CLOPIDOGREL HCL FCT 75MG IN91 SH EU 04 M | $6.2M | 2 | 2.5% |
| 13 | DR REDDYS LABORATORIES LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL TABLETS 75MG 500'SCLOPIDOGREL TABLETS 75MG 6000'S | $6.0M | 6 | 2.4% |
| 14 | INTAS PHARMACEUTICALS LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL BISULPHATE TAB 75MG PACK:4X7CLOPIDOGREL BISULPHATE TAB 75MG PACK:BOX | $5.3M | 19 | 2.1% |
| 15 | MICRO LABS LIMITED CLOPIDOGREL 75 MG TABLETSCLOPIDOGREL/ACIDE ACETYLSALICYLIQUE MYLACLOPIDOGREL TABLETS 75MG (CLOPIDOGREL AR | $5.2M | 20 | 2.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Clopidogrel exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter, June 2019 | Unknown | Unknown | Unknown | Received FDA warning letter for CGMP violations at Unit XI. |
| Mylan Laboratories Limited | Warning Letter, April 201 | Unknown | Unknown | Unknown | FDA warning letter for data integrity issues at Nashik FDF facility. |
| Intas Pharmaceuticals Limited | Warning Letter, July 2023 | Unknown | Unknown | Unknown | FDA warning letter for data integrity violations. |
| Mylan Pharmaceuticals Inc. | Warning Letter, November | Unknown | Unknown | Unknown | FDA warning letter for inadequate change management. |
| Mylan Laboratories Limited (Unit 8) | Warning Letter, Date Unkn | Unknown | Unknown | Unknown | FDA warning letter for solvent contamination issues. |
| Jagsonpal Pharmaceuticals Limited | Warning Letter, February | Unknown | Unknown | Unknown | FDA warning letter for inspection refusal. |
| AACE Pharmaceuticals, Inc. | Warning Letter, May 2025 | Unknown | Unknown | Unknown | FDA warning letter for inadequate CMO oversight. |
| Tower Laboratories Ltd. | Warning Letter, December | Unknown | Unknown | Unknown | FDA warning letter for CGMP violations. |
TransData Nexus reviewed the regulatory standing of 8 leading Clopidogrel exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 8 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Clopidogrel sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," plays a pivotal role in the production of active pharmaceutical ingredients (APIs), including Clopidogrel. The city contributes approximately 40% of India's bulk drug production, earning its reputation as a central hub for pharmaceutical manufacturing. The establishment of Genome Valley, a premier biotech cluster, has further solidified Hyderabad's position in the pharmaceutical sector. This ecosystem supports over 200 life sciences companies, fostering innovation and large-scale production capabilities.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat holds a 33% share in India's drug manufacturing and a 28% share in drug exports, with Ahmedabad and Vadodara being central to this output. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's emphasis on formulations complements Hyderabad's API production, creating a comprehensive supply chain for drugs like Clopidogrel.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Mumbai's strategic location and well-developed port infrastructure facilitate efficient international distribution. The region hosts numerous pharmaceutical companies that leverage these logistical advantages to export products like Clopidogrel to major markets, including the United States and the United Kingdom.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives. These incentives have attracted numerous pharmaceutical companies, contributing to the production and export of various drugs, including Clopidogrel. The region's growth underscores the impact of policy measures in enhancing pharmaceutical manufacturing capabilities.
5Sourcing Recommendations
- Diversify Supplier Base: While AUROBINDO PHARMA LTD and MACLEODS PHARMACEUTICALS LTD are leading exporters, consider engaging with other significant suppliers such as ZENTIVA PRIVATE LIMITED and DR. REDDY'S LABORATORIES LTD to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's API production capabilities for sourcing raw materials and Ahmedabad-Vadodara's expertise in formulations to ensure a robust supply chain for Clopidogrel.
- Optimize Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to facilitate efficient distribution to key markets, particularly the United States and the United Kingdom.
- Monitor Policy Changes: Stay informed about tax incentives and regulatory developments in regions like Baddi-Nalagarh to identify cost-effective manufacturing opportunities.
By strategically engaging with these pharmaceutical clusters and suppliers, TransData Nexus can enhance its supply chain resilience and capitalize on India's robust pharmaceutical manufacturing ecosystem.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Clopidogrel exporters from India
Aurobindo Pharma Limited — Aurobindo's TheraNym partners with Merck for biologics manufacturing
In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma Limited, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: This collaboration is expected to enhance Aurobindo's manufacturing capabilities, potentially increasing Clopidogrel production capacity.
Impact: This collaboration is expected to enhance Aurobindo's manufacturing capabilities, potentially increasing Clopidogrel production capacity.
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's partners with Pharmazz to market Centhaquine in India
In March 2024, Dr. Reddy's Laboratories partnered with Pharmazz Inc. to bring the life-saving drug Centhaquine (Lyfaquin) to India. - IMPACT: While this partnership focuses on Centhaquine, it may strengthen Dr. Reddy's market presence, indirectly benefiting Clopidogrel exports.
Impact: While this partnership focuses on Centhaquine, it may strengthen Dr. Reddy's market presence, indirectly benefiting Clopidogrel exports.
Aurobindo Pharma Ltd. — Aurobindo faces patent litigation over Sensipar® in the U.S.
In June 2024, Amgen Inc. filed a lawsuit against Aurobindo Pharma Ltd. and other companies for alleged infringement of the U.S. Patent No. 9,375,405 related to Sensipar® (cinacalcet). - IMPACT: This litigation may divert resources and attention, potentially affecting Aurobindo's Clopidogrel export operations.
Impact: This litigation may divert resources and attention, potentially affecting Aurobindo's Clopidogrel export operations.
Common Questions — Clopidogrel Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which clopidogrel supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 728 recorded shipments worth $43.2M. MACLEODS PHARMACEUTICALS LTD (190 shipments) and ZENTIVA PRIVATE LIMITED (380 shipments) are also established high-volume exporters.
Q How many clopidogrel manufacturers are there in India?
India has 416 active clopidogrel exporters with a combined export market of $251.3M across 6,037 shipments to 137 countries. The top 5 suppliers hold 50.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for clopidogrel from India?
Average FOB unit price: $2.24 per unit, ranging from $0.00 to $1334.38. Average shipment value: $41.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 416 verified Indian exporters of Clopidogrel ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,037 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 137 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,037 Verified Shipments
416 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists